Canadian application, no grantCanada
Cloning and characterization of a human adenylyl cyclase
CA 2294381 A1 · Owner: Cor Therapeutics, Inc. · Inventors: Tomlinson, James E.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A DNA sequence encoding a human adenylyl cyclase is described. The amino acid sequence of the adenylyl cyclase is also described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 1, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 1, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 1, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 1, 1998
GrantedNo grant recorded
Term endedJuly 1, 2018
Patent numberCA 2294381 A1
Classification (IPC)C12N9/88 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.